FDA Panel Says Pfizer's New Osteoporosis Drug Has Benefits But Use Should Be Restricted A panel that advises the US Food and Drug Administration (FDA) on new drug approvals said the benefits of Pfizer's bone drug Fablyn for treating postmenopausal women with osteoporosis outweighed the risks but that use should be restricted to patients at high risk of fracture or who have tried other treatments without success.
Source: www.medicalnewstoday.comStudy Identifies Proteins That Help Provide Immunity Against HIV Among Commercial Sex Workers In Kenya In a study published Wednesday in the Journal of Proteome Research, researchers from the University of Manitoba, along with participants from Canada's National Microbiology Laboratory and the
Source: www.medicalnewstoday.comLos Angeles Times Examines Differences Between McCain, Palin Over Discussion Of Condom Use In Schools The Los Angeles Times on Saturday examined differences between Republican presidential candidate Sen. John McCain (Ariz.) and his vice presidential running mate Alaska Gov. Sarah Palin (R) over whether condom use should be discussed in schools. According to the Times, McCain and the Republican Party
Source: www.medicalnewstoday.comPharmacy Bodies Pledge To Work As One On White Paper The principal bodies representing the Pharmacy sector have agreed to ensure that the opportunities presented by the White Paper Pharmacy in England: Building on strengths - delivering the future become a reality. The five bodies have put on the record a commitment to work together to deliver the best possible range of high quality services for the ultimate benefit of patients and the public in England.
Source: www.medicalnewstoday.comGAO Report Examines Effects Of Medicare Part D Low-Income Subsidy On Access To Prescription Drugs "Medicare Part D Low Income Subsidy: Assets and Income Are Both Important in Subsidy Denials, and Access to State and Manufacturer Drug Programs Is Uneven,"
Source: www.medicalnewstoday.comNursing Home Prescribing Remains A Cause For Concern Research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown that 51% of nursing home patients are taking inappropriate psychoactive
drugs. A separate study at BPC describes how inappropriate prescribing of psychoactive
drugs may be influenced by organisational and/or treatment culture. Historically, psychotropic medications have been used in nursing homes to sedate the residents, when there is no clinical need.
Source: www.medicalnewstoday.comSimple Test To Detect Fake Medicines The fight against fake
medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether it is counterfeit, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester. The study tested a series of dummy paracetamol tablets made with varying degrees of real
medicine, versus lactose (an ingredient used by counterfeiters to replace the active drug).
Source: www.medicalnewstoday.comNew HIV Protection For Women Vaginal rings, similar to those used for contraception and hormone replacement therapy, could protect women from sexually-transmitted HIV, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
Source: www.medicalnewstoday.comPharmacists Reduce Hospital Visits For Respiratory Patients Patients with chronic obstructive pulmonary disease (COPD) experience 55% fewer hospital admissions and 50% less visits to accident and emergency departments when clinical pharmacists intervene in their care, research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown.
Source: www.medicalnewstoday.comNew Diet Unveiled To Save Millions Of PMS Sufferers PMS charity announces new findings after years of research Figures released from the UK's only PMS Charity NAPS (The National Association for Premenstrual Syndrome) show that 97% of women in Britain are affected by PMS - with 13% taking time off work, costing British business millions of pounds per year*. PMS creates emotional and behavioural symptoms in millions of women in the UK which interferes with day-to-day functioning, affecting their personal and professional lives.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 PM
